We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$565M
AUM Growth
+$18.6M
Cap. Flow
-$16.4M
Cap. Flow %
-2.91%
Top 10 Hldgs %
52.66%
Holding
41
New
8
Increased
7
Reduced
20
Closed
4

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$18.2M
2
HSIC icon
Henry Schein
HSIC
+$12.5M
3
BMY icon
Bristol-Myers Squibb
BMY
+$9.94M
4
HOLX
Hologic
HOLX
+$7.87M
5
QGEN icon
Qiagen
QGEN
+$7.8M

Top Sells

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$10.4M
2
PFE icon
Pfizer
PFE
+$8.78M
3
CNC icon
Centene
CNC
+$8.16M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$7.75M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$7.47M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$143B
$44.6M 7.91%
1,139,985
-225,778
-17% -$8.78M
GILD icon
2
Gilead Sciences
GILD
$167B
$39.8M 7.04%
577,368
-101,265
-15% -$6.76M
MRK icon
3
Merck
MRK
$315B
$35.4M 6.27%
455,447
-75,025
-14% -$5.58M
BMY icon
4
Bristol-Myers Squibb
BMY
$124B
$35M 6.2%
523,493
+152,431
+41% +$9.94M
MDT icon
5
Medtronic
MDT
$106B
$26M 4.6%
209,128
-20,195
-9% -$2.54M
BIIB icon
6
Biogen
BIIB
$30.4B
$25.3M 4.48%
73,043
+23,783
+48% +$7.2M
INCY icon
7
Incyte
INCY
$23.4B
$23.9M 4.23%
284,145
-56,906
-17% -$4.75M
BRKR icon
8
Bruker
BRKR
$8.86B
$23.3M 4.13%
306,650
-71,117
-19% -$4.97M
BDX icon
9
Becton Dickinson
BDX
$43.6B
$23M 4.08%
97,048
-7,284
-7% -$1.75M
CAH icon
10
Cardinal Health
CAH
$53.5B
$21.1M 3.73%
368,931
+44,467
+14% +$2.6M
NUVA
11
DELISTED
NuVasive, Inc.
NUVA
$19.9M 3.53%
293,754
+14,495
+5% +$990K
BSX icon
12
Boston Scientific
BSX
$65.4B
$18.7M 3.31%
436,406
+54,870
+14% +$2.31M
ELV icon
13
Elevance Health
ELV
$80.9B
$17M 3.02%
44,624
-12,147
-21% -$4.64M
CNC icon
14
Centene
CNC
$32.8B
$16.7M 2.96%
229,410
-119,041
-34% -$8.16M
CVS icon
15
CVS Health
CVS
$137B
$16.7M 2.96%
200,441
-39,022
-16% -$3.2M
OGN icon
16
Organon & Co
OGN
$3.55B
$16.7M 2.96%
+552,232
New +$18.2M
BAX icon
17
Baxter International
BAX
$11.7B
$15.5M 2.75%
192,739
-14,212
-7% -$1.19M
ELAN icon
18
Elanco Animal Health
ELAN
$12.9B
$13.8M 2.44%
396,478
-23,501
-6% -$775K
HSIC icon
19
Henry Schein
HSIC
$10B
$12.3M 2.18%
+165,721
New +$12.5M
LH icon
20
Labcorp
LH
$23.2B
$12M 2.13%
50,689
-2,554
-5% -$582K
IONS icon
21
Ionis Pharmaceuticals
IONS
$8.99B
$10.5M 1.86%
263,488
-190,662
-42% -$7.47M
RVTY icon
22
Revvity
RVTY
$12.3B
$10.4M 1.85%
67,661
-49,806
-42% -$7M
BIO icon
23
Bio-Rad Laboratories Class A
BIO
$8.15B
$10.4M 1.84%
16,136
-3,421
-17% -$2.08M
ALNY icon
24
Alnylam Pharmaceuticals
ALNY
$35.7B
$9.84M 1.74%
58,017
-1,772
-3% -$260K
PRGO icon
25
Perrigo
PRGO
$1.48B
$9.39M 1.66%
204,732
-146
-0.1% -$6.47K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2021 Portfolio in Review

As of Q2 2021, Sector Gamma AS held 41 positions worth $565M, up 3.4% from $546M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sector Gamma AS's Q2 2021 filing shows 8 new, 7 increased, 20 reduced and 4 closed positions. Its largest new stake was Organon & Co: 552,232 shares worth $16.7M. The largest sale was LivaNova, an estimated $10.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q2 2021 buy was Organon & Co: 552,232 shares worth $16.7M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q2 2021, an estimated $9.94M increase.
  • Sector Gamma AS's biggest Q2 2021 reduction was LivaNova, cutting an estimated $10.4M.
  • Sector Gamma AS fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $7.75M.
  • Sector Gamma AS's ten largest holdings make up 53% of its $565M portfolio in Q2 2021.
  • Sector Gamma AS opened 8 new positions and closed 4 in Q2 2021.
  • Sector Gamma AS's portfolio value rose 3.4% quarter-over-quarter to $565M.

Based on Sector Gamma AS's 13F filing for Q2 2021, filed 4 Aug 2021.